G'day meerkat,It is probably impossible to set a target on FDA...

G'day meerkat,

It is probably impossible to set a target on FDA approval. That is probably pretty much in the hands of the punters.

We really can't do a reliable valuation untill we see the actual sales.

What we do know, however, is that there are many TB controllers in the USA awaiting this approval.

CST is perhaps a little unique amongst biotechs as a very large number of the shares are very tightly held by the true believers (like me). Most of these are in for the long term, real rewards.

Don't forget that we are also expecting Japan approval anytime now also. This is even bigger than the USA. The knowledge that this is forthcoming may dampen any retrace after the USA approval spike.